Characteristics of the Novel Potassium-Competitive Acid Blocker Vonoprazan Fumarate (TAK-438).
about
Proton pump inhibitors: Risks of long-term use.Helicobacter pylori-Induced Changes in Gastric Acid Secretion and Upper Gastrointestinal Disease.Efficacy of Vonoprazan-Based Triple Therapy for Helicobacter pylori Eradication: A Multicenter Study and a Review of the Literature.Efficacy of Vonoprazan for Gastroesophageal Reflux Symptoms in Patients with Proton Pump Inhibitor-resistant Non-erosive Reflux Disease.Effects of Vonoprazan Compared with Esomeprazole on the Healing of Artificial Postendoscopic Submucosal Dissection Ulcers: A Prospective, Multicenter, Two-Arm, Randomized Controlled Trial.
P2860
Characteristics of the Novel Potassium-Competitive Acid Blocker Vonoprazan Fumarate (TAK-438).
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Characteristics of the Novel P ...... Vonoprazan Fumarate (TAK-438).
@en
type
label
Characteristics of the Novel P ...... Vonoprazan Fumarate (TAK-438).
@en
prefLabel
Characteristics of the Novel P ...... Vonoprazan Fumarate (TAK-438).
@en
P2093
P2860
P1433
P1476
Characteristics of the Novel P ...... Vonoprazan Fumarate (TAK-438).
@en
P2093
Haruyuki Nishida
Hideo Fukui
Hitomi Yamasaki
Kazuyoshi Otake
Keiichi Otsuka
Masatoshi Karashima
Nobuhiro Inatomi
Yoshihiko Tagawa
Yuuichi Sakurai
P2860
P2888
P304
P356
10.1007/S12325-016-0345-2
P407
P577
2016-06-10T00:00:00Z
P6179
1029776559